ARTICLE | Clinical News
Stelara ustekinumab: Phase III data
March 28, 2016 7:00 AM UTC
Top-line data from the double-blind, international Phase III UNITI-1 trial in 741 patients with moderate to severe CD who previously failed or were intolerant to >=1 anti- tumor necrosis factor (TNF) ...